头孢甲肟治疗严重细菌感染
Cefmenoxime therapy of serious bacterial infections.
作者信息
Gombert M E, Glasser L A, Eng R H
出版信息
Antimicrob Agents Chemother. 1984 Apr;25(4):510-2. doi: 10.1128/AAC.25.4.510.
Abstract
The efficacy and safety of cefmenoxime was evaluated in 50 patients with serious bacterial infections. These included 26 pneumonias, 18 urinary tract infections, 2 soft tissue infections, 2 bacteremias, 1 renal abscess, and 1 peritonitis. A satisfactory clinical response was seen in 47 patients (94%). Eosinophilia and thrombocytosis were seen in several patients but were generally mild and transient.
摘要
对50例严重细菌感染患者评估了头孢甲肟的疗效和安全性。其中包括26例肺炎、18例尿路感染、2例软组织感染、2例菌血症、1例肾脓肿和1例腹膜炎。47例患者（94%）出现了令人满意的临床反应。数名患者出现嗜酸性粒细胞增多和血小板增多，但通常程度较轻且为一过性。
相似文献
1
Cefmenoxime therapy of serious bacterial infections.头孢甲肟治疗严重细菌感染
Antimicrob Agents Chemother. 1984 Apr;25(4):510-2. doi: 10.1128/AAC.25.4.510.
2
Clinical efficacy and safety of cefmenoxime in children.头孢甲肟在儿童中的临床疗效与安全性。
Antimicrob Agents Chemother. 1985 Oct;28(4):508-10. doi: 10.1128/AAC.28.4.508.
3
Comparative evaluation of cefmenoxime versus cefoxitin in serious infections.
Am J Med. 1984 Dec 21;77(6A):13-6. doi: 10.1016/s0002-9343(84)80067-4.
4
5
[Clinical trial of cefmenoxime in children].头孢甲肟在儿童中的临床试验
Jpn J Antibiot. 1982 Nov;35(11):2589-98.
6
Ceftizoxime vs. cefotaxime--a comparative randomized multicenter study.
Isr J Med Sci. 1988 Aug;24(8):410-4.
7
Ceftizoxime in moderate-to-severe infections.
J Antimicrob Chemother. 1982 Nov;10 Suppl C:151-7. doi: 10.1093/jac/10.suppl_c.151.
8
Cefmenoxime: clinical evaluation.头孢甲肟：临床评估。
Am J Med. 1984 Dec 21;77(6A):53-9. doi: 10.1016/s0002-9343(84)80076-5.
9
Cefmenoxime. Clinical, bacteriologic, and pharmacologic studies.
Am J Med. 1984 Jul;77(1):72-8. doi: 10.1016/0002-9343(84)90438-8.
10
Cefmenoxime versus cefoxitin in the treatment of serious bacterial infections.
Am J Med. 1984 Dec 21;77(6A):51-2. doi: 10.1016/s0002-9343(84)80075-3.
引用本文的文献
1
Clinical efficacy and safety of cefmenoxime in children.头孢甲肟在儿童中的临床疗效与安全性。
Antimicrob Agents Chemother. 1985 Oct;28(4):508-10. doi: 10.1128/AAC.28.4.508.
2
Treatment of respiratory tract infections with cephalosporin antibiotics.用头孢菌素类抗生素治疗呼吸道感染。
Drugs. 1987;34 Suppl 2:180-204. doi: 10.2165/00003495-198700342-00014.
3
Levels of cefmenoxime in sera and peritoneal tissues of patients undergoing gastrointestinal surgery.接受胃肠手术患者血清和腹膜组织中的头孢甲肟水平。
Antimicrob Agents Chemother. 1992 Jul;36(7):1483-6. doi: 10.1128/AAC.36.7.1483.
本文引用的文献
1
Comparative in vitro activity of new beta-lactam antibiotics against anaerobic bacteria.新型β-内酰胺类抗生素对厌氧菌的体外活性比较
Antimicrob Agents Chemother. 1981 Nov;20(5):600-9. doi: 10.1128/AAC.20.5.600.
2
Susceptibilities of anaerobic bacteria to N-formimidoyl thienamycin (MK0787) and to other antibiotics.厌氧菌对N-甲酰亚胺基硫霉素（MK0787）及其他抗生素的敏感性。
Antimicrob Agents Chemother. 1982 Jun;21(6):1016-22. doi: 10.1128/AAC.21.6.1016.
3
Moxalactam therapy for bacterial infections.莫西拉坦治疗细菌感染。
Arch Intern Med. 1981 Nov;141(12):1607-12.
4
Comparative in vitro susceptibilities of anaerobic bacteria to cefmenoxime, cefotetan, and N-formimidoyl thienamycin.厌氧菌对头孢甲肟、头孢替坦和N-甲酰亚胺基硫霉素的体外敏感性比较
Antimicrob Agents Chemother. 1983 Apr;23(4):626-9. doi: 10.1128/AAC.23.4.626.
5
Comparative in vitro activities of cefmenoxime (SCE-1365) and newer cephalosporin derivatives of clinical utility.头孢甲肟（SCE - 1365）与具有临床应用价值的新型头孢菌素衍生物的体外活性比较
Antimicrob Agents Chemother. 1982 Jun;21(6):999-1002. doi: 10.1128/AAC.21.6.999.
6
In vitro activity and beta-lactamase stability of cefmenoxime.头孢甲肟的体外活性及β-内酰胺酶稳定性
Antimicrob Agents Chemother. 1982 Aug;22(2):316-22. doi: 10.1128/AAC.22.2.316.
Zotero 插件